John A. Bevan

10.4k total citations · 1 hit paper
262 papers, 8.1k citations indexed

About

John A. Bevan is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, John A. Bevan has authored 262 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Physiology, 87 papers in Molecular Biology and 67 papers in Cellular and Molecular Neuroscience. Recurrent topics in John A. Bevan's work include Nitric Oxide and Endothelin Effects (76 papers), Receptor Mechanisms and Signaling (50 papers) and Neuropeptides and Animal Physiology (31 papers). John A. Bevan is often cited by papers focused on Nitric Oxide and Endothelin Effects (76 papers), Receptor Mechanisms and Signaling (50 papers) and Neuropeptides and Animal Physiology (31 papers). John A. Bevan collaborates with scholars based in United States, Sweden and Austria. John A. Bevan's co-authors include Rosemary D. Bevan, Paul L. Huang, Mark C. Fishman, Michael A. Moskowitz, Kenneth D. Bloch, Hiroshi Mashimo, Zhihong Huang, Che Su, Ismail Laher and Joseph E. Brayden and has published in prestigious journals such as Nature, Science and Circulation Research.

In The Last Decade

John A. Bevan

254 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypertension in mice lacking the gene for endothelial nitric oxide synthase

1995 1.7k citations Paul L. Huang, Zhihong Huang et al. Nature profile →

Peers

Countries citing papers authored by John A. Bevan

Since Specialization

Citations

This map shows the geographic impact of John A. Bevan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Bevan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Bevan more than expected).

Fields of papers citing papers by John A. Bevan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Bevan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Bevan. The network helps show where John A. Bevan may publish in the future.

Co-authorship network of co-authors of John A. Bevan

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Bevan. A scholar is included among the top collaborators of John A. Bevan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Bevan. John A. Bevan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intrisic Tone of Cerebral Artery Segments of Human Infants between 23 Weeks of Gestation and Term 1998 ·Pediatric Research ·Rosemary D. Bevan, (unknown), (unknown), (unknown), John A. Bevan	12
2	Hypertension in mice lacking the gene for endothelial nitric oxide synthase breakdown → 1995 ·Nature ·Paul L. Huang, Zhihong Huang, Hiroshi Mashimo, Kenneth D. Bloch, Michael A. Moskowitz, John A. Bevan, Mark C. Fishman	1692
3	Barium inhibits the endothelium-dependent component of flow but not acetylcholine-induced relaxation in isolated rabbit cerebral arteries. 1995 ·Journal of Pharmacology and Experimental Therapeutics ·George C. Wellman, John A. Bevan	53
4	Intraluminal Flow Preferentially Increases Net Sodium Uptake in the Rabbit Facial Vein 1995 ·Journal of Vascular Research ·Daniel Henrion, John A. Bevan	3
5	The Human brain circulation : functional changes in disease 1994 ·Humana Press eBooks ·Rosemary D. Bevan, John A. Bevan	6
6	Pressure and Flow: Are These the True Vascular Neuroeffectors? 1991 ·Journal of Vascular Research ·John A. Bevan	3
7	Early Treatment with Diltiazem Reduces Delayed Cerebral Vascular Narrowing after Subarachnoid Hemorrhage 1988 ·Neurosurgery ·John G. Frazee, John A. Bevan, Rosemary D. Bevan, (unknown), (unknown)	13
8	Calcium and Vascular Myogenic Tone^a 1988 ·Annals of the New York Academy of Sciences ·Ismail Laher, Joyce Hwa, John A. Bevan	9
9	Quantitative Ultrastructural Measurement of Innervation Density, Neurotransmitter Vesicles and Neuromuscular Cleft Width in the Rabbit Central Ear Artery and Its Main Side Branch 1987 ·Journal of Vascular Research ·Reed A. Rowan, John A. Bevan	6
10	Alpha adrenoceptor number limits response of some rabbit arteries to norepinephrine. 1985 ·Journal of Pharmacology and Experimental Therapeutics ·Ismail Laher, John A. Bevan	24
11	Ultrastructure of the Innervation of the Cat Lingual Artery in Relation to Noradrenergic Vasoconstriction, and to Neurogenic Vasodilation Produced by Cholinergic and Nonadrenergic, Noncholinergic Mechanisms 1984 ·Journal of Vascular Research ·Reed A. Rowan, (unknown), John A. Bevan	2
12	Essentials of pharmacology : introduction to the principles of drug action 1983 ·John A. Bevan	4
13	Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals. 1980 ·PubMed ·John A. Bevan, Andrew J. Tofe, James J. Benedict, Marion D. Francis, B.L. Barnett	29
14	Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model. 1980 ·PubMed ·John A. Bevan, (unknown), James J. Benedict, Francis, B.L. Barnett	23
15	Vascular neuroeffector mechanisms : Second International Symposium on Vascular Neuroeffector Mechanisms, Odense, July 29 to August 1, 1975 1976 ·S. Karger eBooks ·John A. Bevan	1
16	UPTAKE OF NICOTINE BY THE SYMPATHETIC NERVE TERMINALS IN THE BLOOD VESSEL 1972 ·Journal of Pharmacology and Experimental Therapeutics ·John A. Bevan, Che Su	16
17	EFFECT OF THE CHELATING AGENTS, EDTA, 2,2'-BIPYRIDINE, 8-HYDROXYQUINOLINE AND PYROPHOSPHORIC ACID, ON NOREPINEPHRINE UPTAKE BY RABBIT AORTA 1968 ·Journal of Pharmacology and Experimental Therapeutics ·Ove A. Nedergaard, (unknown), John A. Bevan	20
18	POSTGANGLIONIC SYMPATHETIC DELAY IN VASCULAR SMOOTH MUSCLE 1966 ·Journal of Pharmacology and Experimental Therapeutics ·John A. Bevan, M. Anthony Verity	2
19	RESPONSE OF VASCULAR SMOOTH MUSCLE TO POTASSIUM AND ITS ANTAGONISM BY PHENOXYBENZAMINE 1963 ·Journal of Pharmacology and Experimental Therapeutics ·John A. Bevan, Jules Osher, Che Su	16
20	ACTION OF TETRAETHYLAMMONIUM CHLORIDE ON THE SYMPATHETIC GANGLIA-PULMONARY ARTERY PREPARATION 1963 ·Journal of Pharmacology and Experimental Therapeutics ·John A. Bevan	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact